Heat Biologics Announces Formation of Biothreat Advisory Board
Former Deputy Assistant Secretary of Defense for Countering Weapons of Mass Destruction, David Lasseter, and Former US Representative Jack Kingston,...
Former Deputy Assistant Secretary of Defense for Countering Weapons of Mass Destruction, David Lasseter, and Former US Representative Jack Kingston,...
STRATHROY, Ontario, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co”, “we”, “us” or the “Company”)...
Agreement allowing work on numerous collaborative research initiatives in the coming yearsDENVER, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations...
GOODMIND™ Psyence Group Announces the Commencement of Online Sales and Distribution of “GOODMIND” Products TORONTO and CAPE TOWN, South Africa,...
BOSTON, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing...
Werewolf Therapeutics to evaluate WTX-124, a systemically-delivered, conditionally activated Interleukin-2 (IL-2) INDUKINE molecule, in combination with KEYTRUDA® (pembrolizumab) as a...
Expanded Depression Indication Further Demonstrates Company’s Leadership PositionBURLINGTON, Mass. and JERUSALEM, Aug. 18, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ...
Back Forty 40s Package Back Forty 40s recyclable packaging, designed for sharing out of the pack. Back Forty 40s Back...
Completed the regulatory process required to ship medical cannabis to Brazil with import permits issued from ANVISA and export permits...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 18, 2021 (GLOBE NEWSWIRE) --...
MS1819 and PERT combination therapy achieves primary and secondary outcome measure endpointsStudy data indicates clinically meaningful improvement in coefficient of fat absorption (CFA) primary...
– No dose-limiting toxicities (DLTs) or clinically relevant adverse events observed as of August 17 using 100 million cells in...
-- BMB proprietary 5-HT2C agonist, BMB-101, shows efficacy in pre-clinical models of Dravet Syndrome/Epilepsy, with lower seizure duration and frequency...
Fourth Quarter Revenue of $18.7 million and full year 2021 Revenue of $76.4 million, each increased 49% from the prior...
Leading proxy advisors Institutional Shareholders Services and Glass Lewis recommend HEXO shareholders vote FOR the Transaction Resolution and the Financing...
Organic growth in Q3 was 11% and reported revenue in DKK was up by 9% to DKK 4,835 million. EBIT...
9M 2020/21Interim financial results, 9M 2020/211 October 2020 - 30 June 2021Coloplast delivered Q3 organic growth of 11% and 33%...
August 18, 2021Announcement no. 14Q2 2021 Report Highlights Solid revenue growth in the first half of 2021 In the first half of...
Press Release Hørsholm, Denmark (August 18, 2021) – Allarity Therapeutics A/S (“Allarity” or the “Company”) yesterday published a notice to...
ORION CORPORATION PRESS RELEASE 18 AUGUST 2021 at 9.00 a.m. EEST Orion Corporation and Alligator Bioscience announce immuno-oncology research collaboration...